ORPHAZYME A/S American Depositary Shares - Sponsored

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ORPHY and buy or sell other stocks, ETFs, and their options commission-free!

About ORPHY

Strategic Partners A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. It provides Arimoclomol program and molecular entities program. 

CEO
Jakob Færch Bendtsen
CEOJakob Færch Bendtsen
Employees
1
Employees1
Headquarters
Copenhagen, Capital Region
HeadquartersCopenhagen, Capital Region
Founded
2009
Founded2009
Employees
1
Employees1

ORPHY Key Statistics

Market cap
1.25K
Market cap1.25K
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
—
Dividend yield—
Average volume
23.63K
Average volume23.63K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$7.48
52 Week high$7.48
52 Week low
$0.0002
52 Week low$0.0002

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.